# Ectopic Pregnancy

Ectopic pregnancy requires rapid exclusion of rupture, localization with transvaginal ultrasonography and serial quantitative hCG, and treatment matched to stability, pregnancy characteristics, follow-up reliability, and fertility priorities. Methotrexate is effective only in carefully selected, closely monitored patients; surgery is definitive for rupture or high-risk disease.

**Clinical question:** How should physicians diagnose, risk-stratify, and manage suspected or confirmed ectopic pregnancy while preserving safety and fertility?

Updated: 2026-08-20T23:40:34.964349Z

## What matters in practice
- Hemodynamic instability, peritoneal signs, syncope, or clinical concern for rupture warrants immediate resuscitation and operative management rather than serial outpatient testing. [1][4]
- For a stable patient with a positive pregnancy test, transvaginal ultrasonography plus quantitative serum hCG and, when nondiagnostic, serial hCG are the core diagnostic strategy. [1][3][13]
- Pregnancy of unknown location is a transient classification—not a diagnosis—and requires follow-up until viable or nonviable intrauterine pregnancy, ectopic pregnancy, or persistent PUL is established. [13]
- Single-dose methotrexate is 50 mg/m² IM with hCG assessment on days 4 and 7; a decline of at least 15% from day 4 to day 7 permits weekly hCG monitoring to resolution. [18]
- Laparoscopy is preferred when surgery is feasible; salpingectomy is generally favored over salpingotomy when the contralateral tube is normal. [13]

## Identify rupture before pursuing diagnostic certainty

Clinical stability determines the pace and setting of evaluation.

Treat ectopic pregnancy as a hemorrhagic emergency when there is hemodynamic instability, acute abdomen, syncope or presyncope, shoulder pain with suspected hemoperitoneum, or escalating abdominal pain. Tubal rupture can cause intraperitoneal hemorrhage and hypovolemic shock; hypotension may be a late finding. [1][4][10]

In an unstable patient, obtain pregnancy testing, type and crossmatch, CBC, and focused imaging only if it does not delay definitive operative care. Ruptured ectopic pregnancy or failed medical management is managed surgically. [1]
- Do not use a low or declining hCG value to exclude rupture; clinical trajectory overrides biomarker interpretation. [12]
- An intrauterine pregnancy reduces the likelihood of a solitary ectopic pregnancy but does not exclude heterotopic pregnancy, particularly after assisted reproduction. [4][13]

## Localize the pregnancy with transvaginal ultrasound and quantitative hCG

Use imaging and hCG together; neither alone reliably establishes location.

In hemodynamically stable patients, perform transvaginal ultrasonography (TVUS) as the initial imaging study, with transabdominal imaging as an adjunct when needed. TVUS should assess the uterine cavity, adnexa, and free intraperitoneal fluid. A definite extrauterine gestational sac containing yolk sac or embryo establishes ectopic pregnancy; an adnexal mass or free fluid increases concern but must be interpreted with the clinical and hCG context. [1][3][4]

Obtain a quantitative serum hCG concurrently. Serial hCG measurement is most useful when TVUS is nondiagnostic; a single value cannot determine pregnancy location or viability. The historical discriminatory-zone concept should not be used as the sole basis for intervention because an absent intrauterine gestation at a given hCG concentration does not prove ectopic pregnancy. [3][11][13]

Pregnancy of unknown location (PUL) describes positive hCG with no intrauterine or extrauterine pregnancy visualized on TVUS. It can ultimately represent viable or nonviable intrauterine pregnancy, ectopic pregnancy, or persistent PUL. Follow patients until the outcome is resolved; risk models may assist PUL triage but are predictive rather than diagnostic. [13]
- Document fertility treatment, prior ectopic pregnancy, tubal surgery or sterilization, pelvic inflammatory disease, smoking, infertility, and pregnancy with an IUD in situ because these increase ectopic risk. [1][4]
- Obtain Rh status as part of early-pregnancy assessment; the supplied evidence does not provide an anti-D immune globulin dosing recommendation.
- Consider uterine aspiration selectively when distinguishing a nonviable intrauterine pregnancy from ectopic pregnancy would change management; this is not a substitute for follow-up of unresolved hCG findings. [1]

### Diagnostic pitfalls

Do not accept an equivocal intrauterine fluid collection as proof of intrauterine pregnancy. In a cohort of patients presenting for abortion, baseline ultrasound suggesting a probable early intrauterine pregnancy provided false reassurance in later-diagnosed ectopic, cesarean-scar, and heterotopic pregnancies. [2]

Serum progesterone and hCG trends may indicate abnormal pregnancy behavior but do not by themselves localize the gestation. [4][13]

*Working interpretation of early-pregnancy findings. [1][3][13]*

| Finding | Interpretation | Next action |
| --- | --- | --- |
| Hemodynamic instability or peritoneal signs with positive pregnancy test | Suspect ruptured ectopic pregnancy regardless of hCG value. [1][4] | Resuscitate, involve gynecologic surgery immediately, and proceed to operative management. [1] |
| Definite extrauterine gestation on TVUS | Ectopic pregnancy confirmed. [4][13] | Select surgery versus medical or expectant management according to stability, anatomy, hCG trajectory, symptoms, and follow-up capability. [13] |
| No intrauterine or extrauterine gestation on TVUS | PUL; not a final diagnosis. [13] | Arrange serial quantitative hCG, repeat TVUS, symptom surveillance, and reliable follow-up until outcome is known. [13] |
| Intrauterine pregnancy identified after assisted reproduction with persistent focal pain or free fluid | Heterotopic pregnancy remains possible. [4][13] | Evaluate adnexa and obtain urgent specialty assessment if concerning findings are present. [13] |

## Choose expectant, medical, or surgical treatment by risk and follow-up capacity

Management is not interchangeable; risk of rupture and ability to complete surveillance are decisive.

For confirmed or strongly suspected tubal ectopic pregnancy, surgery is indicated for rupture, hemodynamic instability, signs of significant intraperitoneal bleeding, contraindication to methotrexate, inability to ensure follow-up, or failed medical or expectant management. Minimally invasive surgery is recommended when feasible. [1][13]

Expectant management can avoid medication and procedural harms in carefully selected early, asymptomatic tubal pregnancies, but failure can cause serious morbidity. Evidence is limited; reported spontaneous resolution rates vary from 30% to 70% according to selection criteria. Use only with close clinical and hCG follow-up and immediate access to emergency evaluation. [13]

Medical treatment is appropriate only for a stable patient with an unruptured ectopic pregnancy, no contraindication to methotrexate, and reliable return for serial testing. Baseline evaluation includes CBC and renal and hepatic function testing. Methotrexate is used for ectopic pregnancy outside its labeled oncology and inflammatory indications; counsel explicitly about off-label use, prolonged surveillance, possible additional dosing, rupture risk during follow-up, and possible need for surgery. [12]
- Features associated with lower likelihood of methotrexate success include higher pretreatment hCG, embryonic cardiac activity, visible gestational sac, and hemoperitoneum beyond the pelvis. [12]
- For low or declining hCG in an asymptomatic, stable patient, expectant management may be preferable to immediate methotrexate; an individual participant data meta-analysis compared these approaches, supporting continued uncertainty about benefit in low-risk disease. [140]
- Follow-up reliability is a safety requirement, not a convenience. In an outpatient public-hospital cohort, loss to follow-up was common and required substantial active outreach. [21]

*Treatment selection for tubal ectopic pregnancy. [1][12][13]*

| Approach | Appropriate clinical setting | Key limitations and monitoring |
| --- | --- | --- |
| Urgent surgery | Hemodynamic instability, rupture or suspected major hemorrhage, severe symptoms, failed medical management, or inability to ensure follow-up. [1][12] | Laparoscopy is preferred when feasible; select salpingectomy or salpingotomy based on tubal status and fertility considerations. [13] |
| Expectant management | Early, asymptomatic, clinically stable tubal pregnancy with falling or low hCG and dependable close follow-up. [12][13] | Resolution is not assured; counsel on emergency symptoms and continue serial hCG until resolved. [13] |
| Systemic methotrexate | Stable, unruptured ectopic pregnancy without contraindications and with reliable serial hCG follow-up. [12][13] | Higher hCG, embryonic cardiac activity, and more extensive hemoperitoneum predict higher failure risk. [12] |

## Use protocolized methotrexate monitoring and act on inadequate hCG decline

Methotrexate reduces trophoblastic proliferation but does not eliminate rupture risk during surveillance.

The commonly used single-dose regimen is methotrexate 50 mg/m² IM on day 0. Measure hCG on days 4 and 7. If hCG falls by at least 15% from day 4 to day 7, continue weekly quantitative hCG until negative. If the decline is less than 15%, administer another 50 mg/m² IM dose on day 7 and reassess according to protocol; plateauing or rising hCG during follow-up may require additional methotrexate or surgery. [18]

A two-dose regimen administers methotrexate 50 mg/m² IM on days 0 and 4, with hCG measured on days 4 and 7. If the day 4-to-day 7 decline is less than 15%, a third dose is given, followed by additional protocol-directed measurements and possible fourth dose or surgery. [18]

In a prospective multicenter cohort, single- and two-dose protocols had similar treatment success and time to resolution; nonrandomized treatment selection likely reflected clinician assessment of baseline risk. [18] Evidence does not establish a universal superiority of either regimen, and guideline-based use of either single- or double-dose treatment is reasonable in appropriately selected tubal ectopic pregnancy. [13]
- Obtain pretreatment CBC, creatinine, and liver function testing. [12]
- Do not use systemic methotrexate when there is a desired coexisting intrauterine pregnancy because of fetal toxicity; heterotopic pregnancy is generally managed by surgical excision of the ectopic gestation. [13]
- Counsel patients that methotrexate is teratogenic; the reviewed guidance advises avoiding conception for 3 months after injection. [12]
- Escalating pain, dizziness, syncope, shoulder pain, or heavy symptoms during methotrexate follow-up require urgent reassessment for rupture. [1][12]

*Methotrexate regimens and hCG triggers. [18]*

| Protocol | Dosing | Monitoring and action |
| --- | --- | --- |
| Single-dose | Methotrexate 50 mg/m² IM on day 0. [18] | Check hCG on days 4 and 7. If day 4-to-day 7 decline is at least 15%, check weekly until negative; if less than 15%, give 50 mg/m² IM on day 7. [18] |
| Two-dose | Methotrexate 50 mg/m² IM on days 0 and 4. [18] | Check hCG on days 4 and 7. If decline is less than 15%, give a third dose and continue protocol-directed monitoring; inadequate subsequent decline prompts further dosing or surgery. [18] |

## Use tubal surgery to control hemorrhage and address fertility goals

The condition of the contralateral tube is central to the salpingectomy-versus-salpingotomy decision.

When operative treatment is required, laparoscopy is preferred when feasible. Salpingectomy removes the affected tube; salpingotomy removes the ectopic pregnancy while preserving the tube but creates risk for persistent trophoblastic tissue and need for postprocedure hCG surveillance. [13][12]

There is no evidence to recommend routine tube-sparing salpingotomy over salpingectomy for most tubal pregnancies when the contralateral tube is normal. Consider patient fertility priorities, contralateral tubal disease, operative findings, and surgeon expertise. [13]

After salpingotomy, serial hCG follow-up is essential because persistent trophoblastic tissue occurs in an estimated 11% to 22% of cases in the reviewed evidence. Routine prophylactic methotrexate is not generally indicated when hCG monitoring is feasible; methotrexate can be used for persistent disease. [12]
- Discuss that subsequent reproductive outcome is influenced substantially by the contralateral tube and underlying tubal disease, not solely by whether the affected tube is preserved. [10][12]
- Patients with prior ectopic pregnancy have elevated recurrence risk and should seek early confirmation of pregnancy location in future pregnancies. [1][17]

## Refer nontubal ectopic pregnancy early to experienced multidisciplinary care

Interstitial, cervical, cesarean-scar, ovarian, and abdominal implantation have distinct hemorrhage risks and limited comparative evidence.

Nontubal ectopic pregnancies are uncommon, diagnostically challenging, and associated with substantial morbidity when diagnosis is delayed. Their rarity limits randomized evidence, so treatment should be individualized in centers with expertise in advanced ultrasonography, minimally invasive gynecologic surgery, hemorrhage control, and interventional radiology when available. [14]

For cesarean-scar, cervical, and interstitial pregnancies, guideline recommendations support selected medical approaches using multidose and/or local methotrexate, often combined with procedural therapy. These are not managed with the same assumptions used for uncomplicated tubal disease. [13]

Do not administer systemic methotrexate when a heterotopic intrauterine pregnancy is desired. Surgical excision of the ectopic component is suggested. [13]
- Cervical ectopic pregnancy carries severe hemorrhage and possible hysterectomy risk; counsel before treatment. [13]
- Interstitial pregnancy terminology is inconsistent in the literature; ensure imaging describes the implantation site precisely rather than relying on “cornual” alone. [13]
- For suspected nontubal implantation, obtain expert TVUS review before uterine evacuation because inappropriate instrumentation can precipitate major hemorrhage. [13][14]

*Selected nontubal ectopic management principles. [13][14]*

| Location or scenario | High-value management point |
| --- | --- |
| Cesarean-scar pregnancy | Consider specialist medical and/or surgical management; guideline options include multidose or local methotrexate in selected patients. [13] |
| Cervical pregnancy | Favor fertility-preserving medical management over dilation and curettage alone in selected patients; counsel about hemorrhage and possible hysterectomy. [13] |
| Interstitial pregnancy | Selected patients may receive multidose and/or local methotrexate; surgery may require laparoscopic cornuotomy or wedge resection. [13] |
| Heterotopic pregnancy with desired intrauterine gestation | Avoid systemic methotrexate; surgical treatment of the ectopic pregnancy is suggested. [13] |

## Continue surveillance until biochemical resolution and provide future-pregnancy planning

Resolution is documented by hCG, not symptom improvement alone.

After methotrexate, continue quantitative hCG monitoring until the result is negative. After expectant management, maintain clinical and hCG surveillance until spontaneous resolution is documented. Immediate reassessment is required for new or worsening pain, syncope, shoulder pain, or symptoms of intraperitoneal hemorrhage. [12][13]

After ectopic pregnancy, address reproductive goals, contraception, and psychological effects. Early evaluation in a subsequent pregnancy is warranted because prior ectopic pregnancy increases recurrence risk. [1][4]
- For patients receiving methotrexate, avoid conception for 3 months according to the cited off-label use guidance. [12]
- Document a clear emergency pathway and actively confirm completion of serial hCG testing; failure to complete follow-up can convert an otherwise appropriate outpatient strategy into unsafe care. [21]

## Common questions

### Can a rising or abnormal hCG trend diagnose ectopic pregnancy?

No. Serial hCG characterizes pregnancy behavior but does not establish location. Combine it with TVUS, symptoms, and follow-up until a definitive outcome is reached. [3][13]

### Does a confirmed intrauterine pregnancy exclude ectopic pregnancy?

Usually it excludes a solitary ectopic pregnancy, but it does not exclude heterotopic pregnancy. Maintain suspicion after assisted reproduction or when pain, adnexal findings, or free fluid are concerning. [4][13]

### When should methotrexate not be chosen?

Do not use it for hemodynamic instability, suspected major hemorrhage or rupture, inability to complete follow-up, important clinical contraindications, or a desired coexisting intrauterine pregnancy. [12][13]

### When is salpingotomy preferred over salpingectomy?

Consider salpingotomy when preserving the affected tube could materially benefit fertility, particularly with contralateral tubal disease. When the opposite tube is normal, evidence does not support routine tube-sparing surgery over salpingectomy. [13]

### What hCG response indicates success after single-dose methotrexate?

A decrease of at least 15% between posttreatment days 4 and 7 permits weekly hCG monitoring until negative. A smaller decline triggers additional treatment or reassessment under protocol. [18]

## References
1. Tubal ectopic pregnancy - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/174?locale=ar
2. Utility of a routine ultrasound for detection of ectopic pregnancies among women requesting abortion: a retrospective review | BMJ Sexual & Reproductive Health — srh.bmj.com — https://srh.bmj.com/content/48/1/22
3. Ectopic Pregnancy Diagnosis and Management Techniques — www.nature.com — https://www.nature.com/nature-index/topics/l4/ectopic-pregnancy-diagnosis-and-management-techniques
4. Ectopic pregnancy | Nature Reviews Disease Primers — www.nature.com — https://www.nature.com/articles/s41572-024-00579-x
5. Identification of noninvasive diagnostic biomarkers for ... — www.nature.com — https://www.nature.com/articles/s41598-022-23374-8
6. Early Pregnancy and Acute Gynaecology (EP15) - 2016 - BJOG — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.14113
7. Diagnosis and Management of Ectopic Pregnancy - 2016 — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.14189
8. Category – Early Pregnancy and Acute Gynaecology - 2019 — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.2_15703
9. Advanced abdominal pregnancy: challenges, update and ... — obgyn.onlinelibrary.wiley.com — https://obgyn.onlinelibrary.wiley.com/doi/10.1111/tog.12808
10. Ectopic Pregnancy : Topics in Emergency Medicine — journals.lww.com — https://journals.lww.com/aenjournal/fulltext/2002/12000/ectopic_pregnancy.3.aspx
11. Diagnosing Ectopic Pregnancy : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/abstract/00006250-200103000-00028~diagnosing-ectopic-pregnancy-decision-analysis-comparing-six
12. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0301211516308168
13. Guideline No. 414: Management of Pregnancy of Unknown Location and Tubal and Nontubal Ectopic Pregnancies — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1701216321000165
14. Nontubal ectopic pregnancies: overview of diagnosis and treatment — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S001502822300701X
15. Ectopic Pregnancy - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/nursing-and-health-professions/ectopic-pregnancy
16. Ectopic Pregnancy Among American Indian and Alaska Native Women, 2002–2009 — stacks.cdc.gov — https://stacks.cdc.gov/view/cdc/30258/cdc_30258_DS1.pdf
17. Current Trends
Ectopic Pregnancy -- United States, 1990-1992 — www.cdc.gov — https://www.cdc.gov/mmwr/preview/mmwrhtml/00035709.htm
18. Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes — www.ajog.org — https://www.ajog.org/article/s0002-9378(16)30385-4/fulltext
19. Ectopic Pregnancy Mortality — Florida, 2009–2010 — www.cdc.gov — https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a2.htm
20. Clinical Policy: Critical Issues in the Initial Evaluation and ... — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(16)31344-0/fulltext
21. Ambulatory diagnosis and medical management of ectopic pregnancy in a public teaching hospital serving indigent women - American Journal of Obstetrics & Gynecology — www.ajog.org — https://www.ajog.org/article/S0002-9378(03)00341-7/fulltext
22. The Diagnosis of Ectopic Pregnancy — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(14)01561-3/fulltext
23. Emergency Physician Ultrasonography for Evaluating ... — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(10)01196-0/pdf
24. Emergency Reproductive Health — www.acep.org — https://www.acep.org/federal-advocacy/Emergency-Care-in-a-Post--Roe-Era

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.